In article <CJLABK.265 at news.cis.umn.edu>, shiv at hiv.med.umn.edu (Shiv A. Prasad) writes:
|>|> Actually it's an immuno-reality. Oral tolerance is now being studied as a
|> treatment from MS, Rheumatoid arthritis, and uveitis (and probably type I
|> diabetes as well). The MS treatment uses myelin. I think it's bovine
|> myelin, otherwise it would be cannibalism :-). The results of a short term
|> study were recently published in Science, and the results were rather
|> impressive. BTW, the Boston group is led by Howard Weiner for anyone who
|> wants more info on oral tolerance.
|>|> --
|> Shiv A. Prasad shiv at lenti.med.umn.edu|> Dept. of Microbiology pras0005 at student.tc.umn.edu|> Univ. of Minnesota
A similar study (by Trentham et al.), using oral administration of chicken
type II collagen to tolerize rheumatoid arthritis patients, was published
in the Sept. 24, 1993 issue of Science.
--
Ken Frauwirth BBB IIIII OO K K EEEEE N N
frauwirt at mendel.berkeley.edu B B I O O K K E NN N
Dept. of Molec. & Cell Bio. BBB I O O KK EEEE N N N
Immunology Division B B I O O K K E N NN
Univ. of Cal., Berkeley BBB IIIII OO K K EEEEE N N
"Later, at Cal, Berkeley..." "Free Huey!" "Kill the pigs!" - from T-AS
